Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GSK enters into drug discovery collaboration with Exscientia
Under the deal, Exscientia will combine its artificial intelligence (AI) knowledge with the expertise of GSK to discover novel and selective small molecules for up to 10 disease-related
Under the deal, Exscientia will combine its artificial intelligence (AI) knowledge with the expertise of GSK to discover novel and selective small molecules for up to 10 disease-related
The company has reported top-line results from Neucourse phase 3 clinical trial in patients with post-herpetic neuralgia and Alday phase 3 clinical trials in patients with fibromyalgia. Mirogabalin
Dubbed SAVOIR, the phase 3 trial will be held globally in five to ten countries to assess the efficacy and safety of savolitinib in comparison with sunitinib. The open-label,
The approval has been followed by a recommendation of the Committee for Medicinal Products for Human Use (CHMP) in May. It allows to market the drug in the
The collaboration intends to come up with a solution to address antibiotic resistance, a global health problem that is making treatment of common infectious diseases difficult and at
The regulatory body has unveiled a list of off-patent and off-exclusivity branded drugs without approved generics, as well as launched a new policy to speed up the assessment
Developed by Novartis’ unit Sandoz, Erelzi has been approved as an alternative option for all indications of the reference drug. Erelzi can be used by physicians to treat rheumatoid
The approval has been granted for Kevzara to treat moderately to severely active RA in adult patients who have responded inadequately or who are intolerant to one or
The company has reported positive data from the primary analysis of the phase III Haven 1 study in adults and adolescents and interim analysis of the phase III
Imraldi has been recommended to be approved for rheumatoid arthritis, juvenile idiopathic arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis, pediatric plaque psoriasis, adult and adolescent hidradenitis suppurativa, Crohn’s disease,